These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38050825)

  • 1. Loss of MTA2-mediated downregulation of PTK7 inhibits hepatocellular carcinoma metastasis progression by modulating the FAK-MMP7 axis.
    Hu HM; Lee HL; Liu CJ; Hsieh YH; Chen YS; Hsueh KC
    Environ Toxicol; 2024 Apr; 39(4):1897-1908. PubMed ID: 38050825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways.
    Hsu WH; Chiou HL; Lin CL; Kao SH; Lee HL; Liu CJ; Hsieh YH
    J Cancer; 2019; 10(26):6716-6725. PubMed ID: 31777601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.
    Chen L; Li M; Li Q; Wang CJ; Xie SQ
    Mol Cancer; 2013 Dec; 12():157. PubMed ID: 24325363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling.
    Wong TLM; Wong TL; Zhou L; Man K; Purcell J; Lee TK; Yun JP; Ma S
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):13-37. PubMed ID: 36202326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.
    Hu YJ; Li HY; Qiu KJ; Li DC; Zhou JH; Hu YH; Zhang FM
    Int J Mol Med; 2014 Oct; 34(4):1081-6. PubMed ID: 25110169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells.
    Yang Y; Qiu R; Zhao S; Shen L; Tang B; Weng Q; Xu Z; Zheng L; Chen W; Shu G; Wang Y; Zhao Z; Chen M; Ji J
    BMC Biol; 2022 Dec; 20(1):294. PubMed ID: 36575438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic, Immunological, and Mutational Analysis of MTA2 in Pan-Cancer and Drug Screening for Hepatocellular Carcinoma.
    Huang X; Tan J; Chen M; Zheng W; Zou S; Ye X; Li Y; Wu M
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
    Zhu S; Deng S; He C; Liu M; Chen H; Zeng Z; Zhong J; Ye Z; Deng S; Wu H; Wang C; Zhao G
    J Pathol; 2018 Jul; 245(3):349-360. PubMed ID: 29708271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 13. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer.
    Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B
    Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
    Lee H; Ryu SH; Hong SS; Seo DD; Min HJ; Jang MK; Kwon HJ; Yu E; Chung YH; Kim KW
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1445-50. PubMed ID: 19702911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.
    Zhou C; Ji J; Cai Q; Shi M; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
    Mol Cancer; 2013 Sep; 12(1):102. PubMed ID: 24010737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis.
    Zhang JN; Wei F; Lei LH; Yang Y; Yang Y; Zhou WP
    Bioengineered; 2021 Dec; 12(2):11728-11739. PubMed ID: 34784846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS; Li HS; Huang JQ; Dong SH; Huang ZJ; Yi W; Zhan GF; Feng JT; Sun JC; Huang XH
    Cancer Lett; 2016 May; 375(1):73-83. PubMed ID: 26944318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
    Lin X; Chang W; Wang Y; Tian M; Yu Z
    Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.